PROCEPT BioRobotics Corporation (PRCT) Free cash flow 2020–2025
PROCEPT BioRobotics Corporation (PRCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$58.3MFY2025 · since FY2020: -$48.6M → -$58.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$58.3M | +43.7% |
| FY2024 | -$103.6M | +22.2% |
| FY2023 | -$133.2M | -60.4% |
| FY2022 | -$83.0M | -43.3% |
| FY2021 | -$57.9M | -19.2% |
| FY2020 | -$48.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRCT financial trends
PRCT RevenuePRCT Net incomePRCT Net marginPRCT Gross profitPRCT Gross marginPRCT Operating incomePRCT Operating marginPRCT Operating cash flowPRCT Capital expendituresPRCT Return on equityPRCT Stock buybacksPRCT Dividends paidPRCT Total assetsPRCT Total liabilitiesPRCT Shareholders’ equityPRCT overview →